ALLISON DEMANY: Open Payments
NPI 1760904866 · SARASOTA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,145 in 37 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $601 · 2025 $1,145
Food & beverage: $1,145
| Company | Payments | Amount |
|---|---|---|
| Eisai Inc. | 11 | $251 |
| GENZYME CORPORATION | 4 | $147 |
| TG Therapeutics, Inc. | 1 | $124 |
| Lilly USA, LLC | 4 | $107 |
| Lundbeck LLC | 1 | $104 |
| Biogen, Inc. | 3 | $73 |
| Alexion Pharmaceuticals, Inc. | 2 | $63 |
| Genentech USA, Inc. | 2 | $60 |
| ABBVIE INC. | 2 | $50 |
| UCB, Inc. | 2 | $38 |
Products named: Leqembi, BRIUMVI, KISUNLA, VYEPTI, ULTOMIRIS, Ocrevus Zunovo, VUMERITY, KESIMPTA.
Industry payments across FL — which companies pay providers there.
